LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 58.21 | 771.67 | 8999 | 8085 | 1.1130 | 1.0642 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 60.44 | 771.67 | 8645 | 8530 | 1.0134 | 1.0077 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 60.44 | 771.67 | 9589 | 8530 | 1.1241 | 1.0686 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 62.66 | 771.67 | 9137 | 8978 | 1.0177 | 1.0099 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 62.66 | 771.67 | 9856 | 8978 | 1.0977 | 1.0534 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 64.88 | 771.67 | 9474 | 9447 | 1.0028 | 1.0016 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 64.88 | 771.67 | 10278 | 9447 | 1.0880 | 1.0472 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.10 | 771.67 | 10066 | 9800 | 1.0271 | 1.0146 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 67.10 | 771.67 | 10656 | 9800 | 1.0873 | 1.0462 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 69.32 | 771.67 | 10414 | 10212 | 1.0198 | 1.0105 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 69.32 | 771.67 | 10842 | 10212 | 1.0617 | 1.0324 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 71.54 | 771.67 | 10734 | 10532 | 1.0191 | 1.0101 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 71.54 | 771.67 | 11235 | 10532 | 1.0667 | 1.0345 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 73.76 | 771.67 | 11103 | 10851 | 1.0232 | 1.0120 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 73.76 | 771.67 | 11552 | 10851 | 1.0645 | 1.0331 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 76.02 | 771.67 | 11448 | 11106 | 1.0307 | 1.0158 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 76.02 | 771.67 | 11841 | 11106 | 1.0661 | 1.0336 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 78.25 | 771.67 | 11680 | 11367 | 1.0275 | 1.0140 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 78.25 | 771.67 | 12208 | 11367 | 1.0739 | 1.0371 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 80.48 | 771.67 | 12075 | 11685 | 1.0334 | 1.0168 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 80.48 | 771.67 | 12533 | 11685 | 1.0726 | 1.0361 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 82.69 | 771.67 | 12265 | 11974 | 1.0243 | 1.0122 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 82.69 | 771.67 | 13020 | 11974 | 1.0874 | 1.0428 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 84.92 | 771.67 | 12627 | 12266 | 1.0294 | 1.0146 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 84.92 | 771.67 | 13223 | 12266 | 1.0780 | 1.0380 | MN20160304_L01 | M15 |